Endo International PLC (USD)
ENDP
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range3.28 | 3.45
52-Wk Range- | -
Last Close3.36
Mkt Cap (m)771.81
Dividend yield-
ISINIE00BJ3V9050
Volume3,556,597.00
Exchange VenueNAS

Company Profile

Endo International PLC is a generics and specialty branded pharmaceutical company. The company sells generic products in the US which includes pain management, urology, central nervous system disorders, immunosuppression, and oncology and among others.

Key Information
Price/Earning-
Price/Book0.00
Price/Sales0.25
P/CF3.05
Rev Growth (3 year avg)-10.09
EPS Growth (3 year avg)-
Operating Margin % 19.97
Net Margin %-14.50
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 08/08/2018
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

http://www.endo.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)2,877.193,268.724,010.273,468.862,947.082,914.36
Operating Income (m)526.58349.57421.20438.39483.53581.87
Net Income (m)-721.32-1,495.04-3,347.07-2,035.43-1,031.47-422.64
Basic EPS-4.91-7.59-15.03-9.12-4.61-1.87
Avg. Diluted Shares Outstanding (m)146.90197.10222.65223.20223.96226.05
Balance Sheet
USD201420152016201720182019
Current Assets (m)3,307.473,475.152,589.462,271.082,343.152,586.22
Non Current Assets (m)7,602.1415,875.1811,685.659,364.507,789.246,803.31
Total Assets (m)10,909.6219,350.3414,275.1111,635.5810,132.399,389.53
Current Liabilities (m)3,099.253,474.312,634.752,220.911,950.101,460.29
Total Liabilities (m)------
Total Equity (m)2,374.765,968.032,701.59484.88-498.28-866.54
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)337.7862.03524.44553.99267.2798.05
Capital Expenditure (m)-85.43-125.74-158.06-125.65-86.40-63.85
Figures are quoted in USD unless stated otherwise
0.04 (1.19%)
$
3.40
Last Price